Vertex Pharmaceuticals
VRTX
#206
Rank
C$146.51 B
Marketcap
C$576.02
Share price
-0.81%
Change (1 day)
-16.84%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2025 (TTM): C$6.44 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are C$12.00 Billion. , an increase over its 2024 earnings that were of C$0.37 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 C$6.32 B1568.4%
2024 C$0.37 B-93.69%
2023 C$6.01 B3.19%
2022 C$5.82 B53.56%
2021 C$3.79 B-12.06%
2020 C$4.31 B118.45%
2019 C$1.97 B120.64%
2018 C$0.89 B1473.64%
2017 C$56.88 M197.6%
2016 C$19.11 M-102.97%
2015 -C$0.65 Billion-28.46%
2014 -C$0.9 Billion-51.5%
2013 -C$1.86 Billion-30584.68%
2012 C$6.08 M-95.47%
2011 C$0.13 B
2009 -C$0.81 Billion
2007 -C$0.57 Billion83.1%
2006 -C$0.31 Billion59.02%
2005 -C$0.2 Billion3.28%
2004 -C$0.19 Billion-38.16%
2003 -C$0.31 Billion
2000 -C$51.7 Million-20.38%
1999 -C$64.93 Million31.62%
1998 -C$49.33 Million91.05%
1997 -C$25.82 Million-36.24%
1996 -C$40.5 Million12.45%
1995 -C$36.01 Million27.4%
1994 -C$28.27 Million-1833.33%
1993 C$1.63 M-112.12%
1992 -C$13.46 Million175%
1991 -C$4.9 Million-12.2%
1990 -C$5.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$45.59 B 620.54%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$8.96 B 41.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$13.31 B 110.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$30.46 B 381.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$12.67 B 100.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-C$0.11 Billion-101.63%๐Ÿ‡บ๐Ÿ‡ธ USA